Fluoguides bestyrelsesformand trækker sig af personlige årsager
Mød børsaktuelle FluoGuide - YouTube
SEB initiates commissioned research on FluoGuide - IPO.se
Important information in English about the transfer to Nasdaq First North - FluoGuide A/S
SEB initiates commissioned research on FluoGuide - IPO.se
VEDTÆGTER/ARTICLES OF ASSOCIATION For FluoGuide A/S (“Selskabet” / the “Company”) CVR-nr./Central Business Register (
FluoGuide ser lovende resultater fra studie
Spotlight welcomes FluoGuide
Maximizing surgical outcomes Making cancer fluorescent - FluoGuide A/S
Fluoguide ser lovende resultater fra studie — MedWatch
Pipeline - FluoGuide A/S
Fluoguide får positive resultater fra tidligt studie – gør klar til klinikken — MedWatch
YEAR END REPORT 2022
Presentations - FluoGuide A/S
Morten Albrechtsen on LinkedIn: FluoGuide has received green light to proceed to fifth dose level with…
First North børs er den suverænt bedste børs for investorer
FluoGuide søger notering på Spotlight | Et nyt dansk medico-selskab gør klar til børsnotering. Morten Albrechtsen, der er CEO i FluoGuide, fortæller her om selskabets første produkt, FG001, der... | By Nordnet
Spotlight Archives - Nyemission
Fluoguide ready for the stock market after successful IPO — MedWatch
FluoGuide A/S - Stock and Shares News | IPO HUB
YEAR END REPORT 2022
Spotlight and Fluoguide talks about IPOs and being a listed company - MVA
FluoGuide A/S is awarded Best IPO in 2019 by the independent IPO Guide